Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Alzheimer's Disease
Recent news which mentions Alzheimer's Disease
< Previous
1
2
3
Next >
FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023
Tags
Alzheimer's disease
Business
World News
From
CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
May 03, 2023
Tags
Biotech and Pharmaceuticals
Politics
Health care industry
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Science
Pharmaceuticals
Business
From
CNBC.com News
March 2023 Miscellany
March 27, 2023
Tags
Prostate Cancer
lung cancer
Merck (MRK)
From
Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
January 17, 2023
Tags
Alzheimer's Disease
Eisai (ESALY)
Anavex Life Sciences (AVXL)
From
Stock Gumshoe
Relevant Updates – December 2022
December 27, 2022
Tags
influenza
Biogen Idec (BIIB)
Bavarian Nordic (BAVA/CO BVNRY BVNKF)
From
Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
Tickers
MOR
RHHBF
RHHBY
RHHVF
Tags
Briefs
MOR
Alzheimer's disease
From
Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
November 13, 2022
Tags
Smoking
Dementia
Make It
From
CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
November 07, 2022
Tickers
SPRC
Tags
medical cannabis
General
SPRC
From
Benzinga
Odd & Ends – October 2022
October 27, 2022
Tags
Biogen Idec (BIIB)
Roche (RHHBF RHHBY)
Amylx Pharmaceuticals (AMLX)
From
Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Tickers
ABOS
ACIU
ALZN
ANVS
Tags
Trading Ideas
LLY
Large Cap
From
Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
lecanemab
News
SVB Leerink
From
Benzinga
Following Up on Your Suggestions – September 2022
September 26, 2022
Tickers
DIET
Tags
Prostate Cancer
diet
NervGen Pharma (NGEN/V NGENF)
From
Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
August 10, 2022
Tickers
DGX
Tags
Quest Diagnostics
Events, Media & Communications
NYSE:DGX
From
3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
August 04, 2022
Tickers
CGTX
Tags
Exclusives
News
Biotech
From
Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
July 19, 2022
Tags
ProMIS Neurosciences (PMN/TO ARFXF)
Dundee Corp (DC/A/TO DDEJF)
Cassava Sciences (SAVA)
From
Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
July 08, 2022
Tickers
ABBV
ALEC
Tags
Small Cap
General
Briefs
From
Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
June 13, 2022
Tags
TauRX Pharmaceuticals
Guest Articles
Alzheimer's Disease
From
Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
May 23, 2022
Tickers
BIIB
Tags
Health Care
Aduhelm
Alzheimer's disease
From
Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
May 10, 2022
Tags
Eisai (ESALY)
Alzheimer's Disease
Doc Gumshoe
From
Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
May 10, 2022
Tickers
BIIB
ESALF
ESALY
Tags
FDA
General
BIIB
From
Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
April 19, 2022
Tickers
SAVA
Tags
Trading Ideas
Health Care
News
From
Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
April 13, 2022
Tickers
LGVN
Tags
Biotech
Health Care
Alzheimer's disease
From
Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
Government
Aduhelm
Alzheimer's disease
From
Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
March 31, 2022
Tickers
LGVN
Tags
Biotech
Benzinga
Alzheimer's disease
From
Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
Market News
News
From
Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
News
Briefs
Biotech
From
Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
March 16, 2022
Tickers
PRTA
Tags
News
Health Care
PRTA
From
Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
March 15, 2022
Tickers
GANX
Tags
Market News
Parkinson’s Disease
Preclinical Phase
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Briefs
News
Health Care
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.